COVID-19 treatment methods based on 3D organoids and ex-vivo platforms are analyzed in this chapter. Initially, the platforms available for cell culture and its working characteristics are explained. Subsequently discusses the organoids with their definition and included their uses in various applications. Further, the chapter extends to describe the uses of different organoids with their use in different stages. Most of these methods utilized the 3D ex-vivo cell culture method to develop organoids and test them over infected tissues. Based on the study in this chapter, it is found that the demonstration of active replication of the human organoids culture system of lungs is found to be more helpful for COVID-19 treatment.
Part of the book: Biotechnology to Combat COVID-19
An organoid is an in-vitro platform that recreates 3D multicellular aggerates to form tissues that fabricate the human cellular environment in the lab and imitate the functionalities of the specific organ or disease. Organoids effectively overcomes the gaps in research between 2D cell line and in-vivo models. For organoid development, both pluripotent stem cells and embryonic stem cells can be utilized, and recently Patient-Derived Organoids (PDO) was developed that overcome the limitations caused by using other cell lines. With the development of many advanced technologies in the field of research, the organoid evolution also progressed slowly into the development of patient-specific organ structures. Since tumor organoids were heterogeneous as well as patient-specific, it has many advantages that aid cancer therapy effectively. Apart from cancer treatment, organoids have a variety of applications in cancer research, the study of tissue-specific models, and also in the analysis of the relationship between tissue-specific cancer with various pathogens. Thus, the development of organoids in an effective way can pave the way for various biomedical applications. This chapter focuses on the trends in the journey of organoid research and the latest technologies developed specifically for organoids.
Part of the book: Organoid Bioengineering